Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Environmental Analytics
Environmental and financial analysis dashboard for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. Industry: WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES
Company Overview for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Highlights
Showing data for FY2023
Operational Environmental Cost
$70m
Operational Environmental Cost Intensity
0.65%
Total Environmental Cost
$74m
Total Environmental Cost Intensity
0.69%
ΔOperational Environmental Cost (2020-2023)
$44m
Decoupling Rate (2020-2023)
-34%
Adjusted EBITDA
N/A
Adjusted EBITDA Margin
N/A
Environmental cost statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 16.04% | 47.92% | 275.77% | ||
| 0.07% | 0.07% | 0.11% | 0.38% | |
| -6.28% | 43.17% | 11.81% | ||
| 0.21% | 0.17% | 0.26% | 0.27% | |
| $26m | $25m | $37m | $70m | |
| -0.83% | 44.53% | 89.05% | ||
| 0.27% | 0.24% | 0.36% | 0.65% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | 0.04% | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | 0.69% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2023
Integrated financial analysis
Highlights
Showing data for FY2023
Adjusted EBITDA Margin
N/A
Adjusted EBIT Margin
N/A
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$9,431m | $10,829m | $10,183m | $10,648m | |
| 14.82% | -5.96% | 4.56% | ||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
| ENVIRONMENTAL COST DATA | ||||
$26m | $25m | $37m | $70m | |
| 0.27% | 0.24% | 0.36% | 0.65% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2023
Industry benchmark
WHOLESALE OF HOUSEHOLD GOODS
Scope 1 (% of Sales)
0.38%
Scope 2 (% of Sales)
0.27%
Operational Environmental Cost Intensity
0.65%
Scope 3 (% of Sales)
0.04%
Total Environmental Cost Intensity
0.69%
Selected peer group
Showing data for FY2023
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | CN | $70m | 0.65% |
Loading similar companies data...
Industry distribution
Showing data for FY2023
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2023
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $449m | 75.10% | N/A | N/A |
Energy-related activities (3) | $28m | 4.61% | N/A | N/A |
Upstream transportation (4) | $32m | 5.34% | N/A | N/A |
Waste (5) | $4m | 0.74% | N/A | N/A |
Business travel (6) | $5m | 0.76% | N/A | N/A |
Commuting (7) | $1m | 0.14% | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $34m | 5.68% | N/A | N/A |
Processing of products (10) | $16m | 2.69% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $30m | 4.95% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $598m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2023